Print Page  |  Close Window

Investor Overview

NASDAQ: XBIT1.116.99Data provided by Nasdaq.
Minimum 15 minutes delayed.

XBiotech is building on a foundation of remarkable new therapies, innovative approaches to commercialization and a commitment to realizing treatments for unmet medical needs worldwide.

Recent News
03/27/17XBiotech Announces On-Time Submission to the EMAPrinter Friendly Version
03/23/17XBiotech Announces Addition of Dr. Dirk Arnold to its Scientific Advisory BoardPrinter Friendly Version
03/09/17XBiotech to Provide Fourth Quarter and Full Year 2016 Business UpdatePrinter Friendly Version

Read more »

Upcoming Events

There are currently no events scheduled.

Read more »